Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 8:17:1504424.
doi: 10.3389/fnmol.2024.1504424. eCollection 2024.

Urine miRNA signature as potential non-invasive diagnostic biomarker for Hirschsprung's disease

Affiliations

Urine miRNA signature as potential non-invasive diagnostic biomarker for Hirschsprung's disease

Abhijit Sreepada et al. Front Mol Neurosci. .

Abstract

Hirschsprung's disease (HSCR) is characterized by congenital absence of ganglion cells in the gastrointestinal tract, which leads to impaired defecation, constipation and intestinal obstruction. The current diagnosis of HSCR is based on Rectal Suction Biopsies (RSBs), which could be complex in newborns. Occasionally, there is a delay in diagnosis that can increase the risk of clinical complications. Consequently, there is room for new non-invasive diagnostic methods that are objective, more logistically feasible and also deliver a far earlier base for a potential surgical intervention. In recent years, microRNA (miRNA) has come into the focus as a relevant early marker that could provide more insights into the etiology and progression of diseases. Therefore, in the search of a non-invasive HSCR biomarker, we analyzed miRNA expression in urine samples of HSCR patients. Results from 5 HSCR patients using microarrays, revealed hsa-miR-378 h, hsa-miR-210-5p, hsa-miR-6876-3p, hsa-miR-634 and hsa-miR-6883-3p as the most upregulated miRNAs; while hsa-miR-4443, hsa-miR-22-3p, hsa-miR-4732-5p, hsa-miR-3187-5p, and hsa-miR-371b-5p where the most downregulated miRNAs. Further search in miRNAwalk and miRDB databases showed that certainly most of these dysregulated miRNAs identified target HSCR associated genes, such as RET, GDNF, BDNF, EDN3, EDNRB, ERBB, NRG1, SOX10; and other genes implied in neuronal migration and neurogenesis. Finally, we could also validate some of these miRNA changes in HSCR urine by RT-qPCR. Altogether, our analyzed HSCR cohort presents a dysregulated miRNA expression presents that can be detected in urine. Our findings open the possibility of using specific urine miRNA signatures as non-invasive HSCR diagnosis method in the future.

Keywords: Hirschsprung’s disease (HSCR); enteric nervous system (ENS); microRNA (miRNA); non-invasive diagnostic; urine extracellular vesicles.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Overview of microarray analysis. (A) Heatmap of relative miRNAs expression. Differential expression is shown between Controls and HSCR samples, color scale represents up- (red), no threshold (gray), or downregulation (blue). (B) Volcano plot showing miRNAs distribution after ANOVA analysis.
Figure 2
Figure 2
(A) Overview of RT-qPCR analysis of the selected miRNAs in HSCR urine samples compared to controls: miR3187-5p (F.N Test p = 0.000002), miR4732-5p (F.N Test p = 0.000015), miR6876-3p, miR-6883-3p. (B) Fold change comparison of 2 − ∆∆Ct from HSCR to control samples (HSCR/Controls).

References

    1. Benz F., Roy S., Trautwein C., Roderburg C., Luedde T. (2016). Circulating MicroRNAs as biomarkers for Sepsis. Int. J. Mol. Sci. 17:78. doi: 10.3390/ijms17010078, PMID: - DOI - PMC - PubMed
    1. Bertoli G., Cava C., Castiglioni I. (2015). MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics 5, 1122–1143. doi: 10.7150/thno.11543, PMID: - DOI - PMC - PubMed
    1. Braun Y., Friedmacher F., Theilen T., Fiegel H. C., Weber K., Harter P. N., et al. . (2024). Diagnosis of Hirschsprung disease by analyzing acetylcholinesterase staining using artificial intelligence. J. Pediatr. Gastroenterol. Nutr. 79, 729–737. doi: 10.1002/jpn3.12339, PMID: - DOI - PubMed
    1. Calkins C. (2018). Hirschsprung disease beyond infancy. Clin. Colon Rectal Surg. 31, 051–060. doi: 10.1055/s-0037-1604034 - DOI - PMC - PubMed
    1. Camilleri M., Wieben E., Eckert D., Carlson P., Hurley O’Dwyer R., Gibbons D., et al. . (2019). Familial chronic megacolon presenting in childhood or adulthood: seeking the presumed gene association. Neurogastroenterol. Motil. 31:e13550. doi: 10.1111/nmo.13550, PMID: - DOI - PMC - PubMed